Several studies (Moreau et al., 2005; Sun et al., 2021; Du et al., 2020; Ono et al., 2001) have also shown that elevated serum IL-6 was associated with disease severity in patients with ALS. Here, IL6 is linked to amyotrophic lateral sclerosis.